Read More Pharma Industry News From metabolism to genetics: Can ARO-PNPLA3 change the MASH playbook Can ARO-PNPLA3 reshape MASH drug development? Discover how Madrigal Pharmaceuticals, Inc. is expanding into precision therapies. bySoujanya RaviMay 8, 2026